New Hope For Early Stage Non-Small Cell Lung Cancer Patients: Immunotherapy After Surgery Lowers Risk of Recurrence

Published May 21, 2021

New Hope For Early Stage Non-Small Cell Lung Cancer Patients: Immunotherapy After Surgery Lowers Risk of Recurrence

NOW
PLAYING
New Research: People With Cancer Prefer Telemedicine Appointments
NOW
PLAYING
New Research Underscores Importance of Genetic Testing in Non-Smokers' Lung Cancer Tumors
NOW
PLAYING
Cancer-Free College Student Reconnects With Lifesaving Leukemia Nurse
NOW
PLAYING
Immunotherapy Saved Lung Cancer Survivor Oswald Peterson
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.